http://ir.unilife.com/releasedetail.cfm?ReleaseID=789950AS...

http://ir.unilife.com/releasedetail.cfm?ReleaseID=789950

AS talking about R&D costs and these being the lifeblood of the company. Says they have deals and customers in mind when spending.

Talking about growth in patent applications made (patents held??) over the year.

Says the expenditure on R&D has not been realised or recognised by the market.

Restating belief that the business model will be realised and that the Sanofi deal is exciting, but not when compared to what is coming up.